COMPOSITIONS OF MATTER FROM UNSATURATED NITRILES

NOVEL ADAMANTYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

N-(3-(2-(4-CHLOROPHENOXY)ACETAMIDO)BICYCLO[1.1.1] PENTAN-1-YL)-2-CYCLOBUTANE-1- CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES

Antibacterial compounds and methods of making and using same

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

PROCESS FOR THE PREPARATION OF ALPHA-ACYLOXY BETA-FORMAMIDO AMIDES

Fluorinated arylalkylaminocarboxamide derivatives

Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis

Aminotetralin compounds as mu opioid receptor antagonists

Process for the preparation of α-acyloxy β-formamido amides

PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS

Aminotetralin compounds as mu opioid receptor antagonists

Novel Therapeutic Compounds

NOVEL THERAPEUTIC COMPOUNDS

Process for the synthesis of 3-amino-3-cyclobuthylmethyl-2-hydroxypropionamide or salts thereof

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 3-(AMINO)-3-CYCLOBUTYLMETHYL-2-HYDROXY-PROPIONAMIDE OR SALTS THEREOF

Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives

CYSTEINE PROTEASE INHIBITORS

Aminotetralin compounds as mu opioid receptor antagonists

Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof

Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases

Compounds for inhibiting insulin secretion and methods related thereto

Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof